Amyotrophic lateral sclerosis and animals models;Sclérose latérale amyotrophique et modèles animaux

Revue Neurologique

Volumn 157, Issue 11 I, 2001, Pages 1351-1361

  Chritin, M ^a   Besson, G ^a   Mallaret, M ^a   Savasta, M ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROTOXIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; CLINICAL FEATURE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE COURSE; GENETIC ANALYSIS; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; SPINAL CORD MOTONEURON; SURVIVAL; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BRAIN; DISEASE MODELS, ANIMAL; HUMANS; MOTOR NEURON DISEASE; MOTOR NEURONS; SPINAL CORD; SURVIVAL RATE;

EID: 0035214303     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (120)

1. Recessive amyotrophic lateral sclerosis families with the D90A SOD1 mutation share a common founder: Evidence for a linked protective factor
2. Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis
3. The role of immune processes in amyotrophic lateral sclerosis pathogenesis
4. Amyotrophic lateral sclerosis associated with homozygosity for an Asp 90 Ala mutations in Cu-Zn superoxide dismutase
5. Lower motor neuron degeneration associated with type C RNA virus infection in mice: Neuropathological features
6. Immunologicals models of amyotrophic lateral sclerosis
7. Evidence for autoimmunity in amyotrophic lateral sclerosis
8. Progressive motor neuron impairment in an animal model of familial amyotrophic lateral sclerosis
9. Beneficial effects of lysine acetylsalicylate, a soluble salt of aspirin, on motor performance in a transgenic model of amyotrophic lateral sclerosis
10. The loss of motoneurons corresponding to specific muscle in the wobbler mutant mouse
11. Late onset of motor neurons in mice overexpressing wild-type peripherin
12. ALS, SOD, and peroxynitrite
13. Detection and cellular localization of enterovirus RNA sequences in spinal cord of patients with SLA
14. Plasminogen activators in the neuromuscular system of the wobbler mutant mouse
15. Transgenic mouse models of alzheimer's disease and amyotrophic lateral sclerosis
16. Motor neuron degeneration of mice is a model of neuronal ceroid lipofuscinosis (Batten's disease)
17. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions
18. Chemical cross-linking analyses of ox neurofilaments
19. Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis
20. The axonal pathology in chronic IDPN intoxication
21. Mechanisms of selective motor neuron death in transgenic mouse models of motor neuron disease
22. Hereditary canine spinal muscular atrophy
23. Animal models of degenerative neurological disease
24. Hereditary canine spinal muscular atrophy: Canine motor neuron disease
25. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: A mouse model of amyotrophic lateral sclerosis
26. Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase
27. Oxidative stress, glutamate, and neurodegenerative disorders
28. Equine motor neuron disease: A preliminary report
29. Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis
30. Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu, Zn SOD, and in mice overexpressing wild type human SOD: A model of familial amyotrophic lateral sclerosis
31. Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase
32. An hereditary motor neurone disease with progressive denervation of muscle in the mouse: The mutant "wobbler"
33. Carboxyfullerenes as neuroprotective agents
34. Amyotrophic lateral sclerosis-a multifactorial disease
35. Experimental autoimmune motoneuron disease
36. IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis
37. Lethal retrograde axoplasmic transport of doxorubicin (adriamycin) to motor neuron. A toxic motor neuronopathy
38. Transgenic mice with increased Cu/Zn-superoxide dismutase activity: Animal model of dosage effects in Down syndrome
39. Variants of the human neurofilament subunit are associated with the development of amyotrophic lateral sclerosis
40. Inhibition of ICE slows ALS in mice
41. Effects of peroxynitrite-induced protein modifications on tyrosine phosphorylation and degradation
42. Animals models for motor neuron disease
43. Slow axonal transport of neurofilaments proteins: Impairment by β, β-iminodipropionitrile administration
44. The use of transgenic mouse models of amyotrophic lateral sclerosis in preclinical drug studies
45. Transgenic animals models of familial amyotrophic lateral sclerosis
46. Transgenic animal models of amyotrophic lateral sclerosis
47. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation
48. Pathogenic mechanisms in familial amyotrophic lateral sclerosis due to mutation of Cu, Zn superoxide dismutase
49. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial lateral sclerosis
50. Riluzole preserves motor function in a transgenic model of familial amyotrophic lateral sclerosis
51. Genetically engineered animal models of human neurodegenerative disease
52. Neurofibrillary accumulation in the zebra (equus burchelli)
53. Cytopathology of amyotrophic lateral sclerosis
54. Neuropathology of ALS: An overview
55. The copper chelator d-penicillamine delays onset of disease and extends survival in a transgenic mousemodel of familial amyotrophic lateral sclerosis
56. Clinical and electrophysiological features of pyramidal disfunction in macaques fed Lathyrus sativus and IDPN
57. ALS
58. Polio antibodies and HLA antigens in amyotrophic lateral sclerosis
59. Wobbler, a mutation affecting motoneuron survival and gonadal functions in the mouse, maps to proximal chromosome 11
60. Neuromuscular function impairment is not caused by motor neuron loss in FALS mice: An electromyographic study
61. Life extension in a transgenic mouse model of familial amyotrophic lateral sclerosis by genetically mediated copper deprivation
62. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis
63. Massive mitochondrial degeneration in motor neurons neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1
64. Bcl-2 prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis
65. A mutant neurofilament subunit causes massive, selective motor neurone death: Implications for the pathogenesis of human motor neurone disease
66. Excitotoxicity in ALS
67. Animals models for motor neuron diseases: Research directions
68. Extra-neurofilament NF-L subunits rescue motor neuron disease caused by overexpression of the human NF-H gene in mice
69. Autosomal dominance in a lateonset motor neuron disease in the mouse
70. Mapping of the motor neuron degeneration (mnd) gene, a mouse model of amyotrophic lateral sclerosis
71. Histopathology of the late-onset motor neuron degeneration (Mnd) mutant in the mouse
72. Peripherin immunoreactive structures in amyotrophic lateral sclerosis
73. Prolonged intracerebral infection with poliovirus in asymptomatic mice
74. The murine motor neuron disease (the wobbler mouse): Degeneration and regeneration of the lower motor neuron
75. Vacuolated anterior horn cells in wobbler mouse motor neuron disease: Peripheral axons and regenerative capacity
76. Animals models of amyotrophic lateral sclerosis. «Pathogenesis and therapy of amyotrophic lateral sclerosis»
77. Covalent cross-linking of neurofilament proteins by oxidatived catechols as a potential mechanism of Lewy body formation
78. Quantitative immunocytochemical analysis of the spinal cord in G86R superoxide dismutase transgenic mice: Neurochemical correlates of selective vulnerability
79. Time course of neuropathology in the spinal cord of G86R superoxide dismutase transgenic mice
80. Light and electron microscopic distribution of the AMPA receptor subunit, GluR2, in the spinal cord of control and G86R mutant superoxide dismutase transgenic mice
81. Superoxide dismutase and neurofilament transgenic models of amyotrophic lateral sclerosis
82. The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu, Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease
83. Histometric characteristics and regenerative capacity in wobbler mouse motor neuron disease
84. Amyotrophic lateral sclerosis and polio: Is there an association?
85. Accumulation of the adenosine triphosphate synthase subunit C in the mnd mutant mouse. A model for neuronal ceroid lipofuscinosis
86. Animals models of ALS
87. Familial amyotrophic lateral sclerosis and transgenic models
88. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury
89. Therapeutic benefits of putrescine-modified catalase in a transgenic mouse model of familial amyotrophic lateral sclerosis
90. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis
91. Analysis of the KSP repeat of the neurofilament heavy subunit in familial amyotrophic lateral sclerosis
92. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
93. Abnormal excitatory amino acid metabolism in lateral amyotrophic sclerosis
94. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis
95. Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis, "Pathogenesis and therapy of amyotrophic lateral sclerosis"
96. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis
97. Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis
98. Excitotoxicity hypothesis
99. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate
100. SOD1 mutation is associated with accumulation of neurofilaments in amyotrophic lateral sclerosis
101. Autosomal dominant inheritance of hereditary canine spinal muscular atrophy
102. A new mouse mutant with progressive motor neuronopathy
103. Mutations in all five exons of SOD1 may cause ALS
104. Mice lacking cytosolic copper/zinc superoxide dismutase display a distinctive motor axonopathy
105. Adult-onset motor neuron disease in three cats
106. Spontaneous lower motor neuron disease in rabbits (oryctologus cuniculus)
107. Linkage of a gene causing amyotrophic lateral sclerosis tochromosome 21 and evidence of genetic-locus heterogeneity
108. Experimental immune-mediated motor neuron disease: Models for human ALS
109. Phosphorylated high molecular weigh filament protein in lower motor neurons in amyotrophic lateral sclerosis and other degenerative diseases involving ventral horn cells
110. Lathyrism: Evidence of role of the neuroexcitatory amino acids BOAA
111. Guam amyotrophic lateral sclerosis-Parkinsonism dementia linked to a plant excitant neurotoxin
112. Chronic aluminium-induced motor neuron degeneration: Clinical, neuropathological and molecular biological aspects
113. Lymphocytic infiltration in the spinal cord of patients with amyotrophic lateral sclerosis
114. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions
115. Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor disease
116. Tyrosine modifications by reactive nitrogen species: A closer look
117. Retroviral interference with neuronotrophic signaling in human motor neuron disease
118. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria
119. Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neurone disease
120. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation